DAYLI Partners
Venture Capital
Seoul-based venture capital firm founded in 2018, specializing in bio-healthcare and financials-governance sector investments.
Seoul, South Korea · 5+ investments · 5 portfolio companies
Seed
Early Stage
Biotech
Healthcare
Medical Devices
- Headquarters
- Seoul, South Korea
- Founded
- 2018
- Website
- dayli.partners
- Portfolio Companies
- 5
- Total Investments
- 5
- Last Investment
- Sep 2024
- Geographic Focus
- South Korea
Investment Thesis
Invest in next-generation bio-healthcare and financials-governance companies through expertise-driven, execution-focused strategies.
DAYLI Partners is a Venture Capital firm based in Seoul, South Korea. It has made 5 investments in Biotech and Healthcare, including Ranelagh, Hyperfine Research and PhAST.
Portfolio5
Investment History
Sign up to view investment history
Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.